Cargando…

Community pharmacists’ perspectives on cardiovascular disease pharmaceutical care in the United Arab Emirates: a questionnaire survey-based analysis

Background: Community pharmacists play an intermediary role between prescribing physicians and patients in the United Arab Emirates (UAE) and thus are responsible for ensuring that patients receive optimal cardiovascular disease (CVD) pharmaceutical care. Methods: we used a cross-sectional design to...

Descripción completa

Detalles Bibliográficos
Autores principales: Jairoun, Ammar Abdulrahman, Al-Himyari, Sabaa Saleh, Shahwan, Moyad, Al Ani, Mina, Habeb, Mustafa, Jairoun, Maimona, Zyoud, Sa’ed H., Alkhanani, Mustfa Faisal, Alhasani, Reem Hasaballah, Hakami, Alqassem Y., Ainousah, Bayan A., Alshehri, Fahad S., Alorfi, Nasser M., Suliman, Abdulhaq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509554/
https://www.ncbi.nlm.nih.gov/pubmed/37736347
http://dx.doi.org/10.3389/fphar.2023.1237717
_version_ 1785107757040402432
author Jairoun, Ammar Abdulrahman
Al-Himyari, Sabaa Saleh
Shahwan, Moyad
Al Ani, Mina
Habeb, Mustafa
Jairoun, Maimona
Zyoud, Sa’ed H.
Alkhanani, Mustfa Faisal
Alhasani, Reem Hasaballah
Hakami, Alqassem Y.
Ainousah, Bayan A.
Alshehri, Fahad S.
Alorfi, Nasser M.
Suliman, Abdulhaq
author_facet Jairoun, Ammar Abdulrahman
Al-Himyari, Sabaa Saleh
Shahwan, Moyad
Al Ani, Mina
Habeb, Mustafa
Jairoun, Maimona
Zyoud, Sa’ed H.
Alkhanani, Mustfa Faisal
Alhasani, Reem Hasaballah
Hakami, Alqassem Y.
Ainousah, Bayan A.
Alshehri, Fahad S.
Alorfi, Nasser M.
Suliman, Abdulhaq
author_sort Jairoun, Ammar Abdulrahman
collection PubMed
description Background: Community pharmacists play an intermediary role between prescribing physicians and patients in the United Arab Emirates (UAE) and thus are responsible for ensuring that patients receive optimal cardiovascular disease (CVD) pharmaceutical care. Methods: we used a cross-sectional design to assess the perceptions and practices of community pharmacists concerning pharmaceutical care for patients with CVD. A trained researcher visited randomly selected community pharmacies and used a structured questionnaire to conduct in-person interviews with pharmacists. The questionnaire collected demographic data and information on perceptions and practices regarding CVD pharmaceutical care. Results: Five hundred and fifty-one participants were recruited. The average participant age (mean ± SD) was 35 ± 2.7 years. The average perception score regarding CVD prevention and management was 75.6% (95% confidence interval [CI] 77.1%–74.2%), and the average practice score for CVD prevention and management was 87.1% (95% CI 76.5%–79.6%). Bivariate analysis revealed that gender (p = 0.001), education level (p < 0.001), pharmacy position (p = 0.004), work experience (p < 0.001), number of patients served per day (p < 0.001) and being trained on CVD prevention and management (p < 0.001) were significantly associated with perceptions about the prevention and management of CVD. Better practice scores were seen among older participants (OR 1.01; 95% CI 1–1.019), postgraduates (OR 1.77; 95% CI 1.66–1.89), workers at chain pharmacies (OR 1.24; 95% CI 1.11–1.39), pharmacists in charge (OR 1.22; 95% CI 1.01–1.47), pharmacists with >10 years of experience (OR 11.3; 95% CI 6.01–15.62), pharmacists with 6–10 years of experience (OR 4.42; 95% CI 3.90–5) and pharmacists trained on CVD prevention and management (OR 1.29; 95% CI 1.15–1.46). Conclusion: Pharmacy practitioners working in community pharmacies in the UAE actively engage in delivering pharmaceutical care to patients, playing a role in CVD management and prevention. However, they showed low levels of involvement in other healthcare services, specifically in screening and measuring patients’ weight, glucose levels, and blood pressure, monitoring treatment responses, maintaining medical records, and reviewing medication refill histories. Activities such as educating patients, providing medication counseling, offering support for treatment adherence, and fostering collaborative relationships with other healthcare providers should be encouraged among UAE community pharmacists to ensure the provision of high-quality patient care.
format Online
Article
Text
id pubmed-10509554
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105095542023-09-21 Community pharmacists’ perspectives on cardiovascular disease pharmaceutical care in the United Arab Emirates: a questionnaire survey-based analysis Jairoun, Ammar Abdulrahman Al-Himyari, Sabaa Saleh Shahwan, Moyad Al Ani, Mina Habeb, Mustafa Jairoun, Maimona Zyoud, Sa’ed H. Alkhanani, Mustfa Faisal Alhasani, Reem Hasaballah Hakami, Alqassem Y. Ainousah, Bayan A. Alshehri, Fahad S. Alorfi, Nasser M. Suliman, Abdulhaq Front Pharmacol Pharmacology Background: Community pharmacists play an intermediary role between prescribing physicians and patients in the United Arab Emirates (UAE) and thus are responsible for ensuring that patients receive optimal cardiovascular disease (CVD) pharmaceutical care. Methods: we used a cross-sectional design to assess the perceptions and practices of community pharmacists concerning pharmaceutical care for patients with CVD. A trained researcher visited randomly selected community pharmacies and used a structured questionnaire to conduct in-person interviews with pharmacists. The questionnaire collected demographic data and information on perceptions and practices regarding CVD pharmaceutical care. Results: Five hundred and fifty-one participants were recruited. The average participant age (mean ± SD) was 35 ± 2.7 years. The average perception score regarding CVD prevention and management was 75.6% (95% confidence interval [CI] 77.1%–74.2%), and the average practice score for CVD prevention and management was 87.1% (95% CI 76.5%–79.6%). Bivariate analysis revealed that gender (p = 0.001), education level (p < 0.001), pharmacy position (p = 0.004), work experience (p < 0.001), number of patients served per day (p < 0.001) and being trained on CVD prevention and management (p < 0.001) were significantly associated with perceptions about the prevention and management of CVD. Better practice scores were seen among older participants (OR 1.01; 95% CI 1–1.019), postgraduates (OR 1.77; 95% CI 1.66–1.89), workers at chain pharmacies (OR 1.24; 95% CI 1.11–1.39), pharmacists in charge (OR 1.22; 95% CI 1.01–1.47), pharmacists with >10 years of experience (OR 11.3; 95% CI 6.01–15.62), pharmacists with 6–10 years of experience (OR 4.42; 95% CI 3.90–5) and pharmacists trained on CVD prevention and management (OR 1.29; 95% CI 1.15–1.46). Conclusion: Pharmacy practitioners working in community pharmacies in the UAE actively engage in delivering pharmaceutical care to patients, playing a role in CVD management and prevention. However, they showed low levels of involvement in other healthcare services, specifically in screening and measuring patients’ weight, glucose levels, and blood pressure, monitoring treatment responses, maintaining medical records, and reviewing medication refill histories. Activities such as educating patients, providing medication counseling, offering support for treatment adherence, and fostering collaborative relationships with other healthcare providers should be encouraged among UAE community pharmacists to ensure the provision of high-quality patient care. Frontiers Media S.A. 2023-09-05 /pmc/articles/PMC10509554/ /pubmed/37736347 http://dx.doi.org/10.3389/fphar.2023.1237717 Text en Copyright © 2023 Jairoun, Al-Himyari, Shahwan, Al Ani, Habeb, Jairoun, Zyoud, Alkhanani, Alhasani, Hakami, Ainousah, Alshehri, Alorfi and Suliman. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Jairoun, Ammar Abdulrahman
Al-Himyari, Sabaa Saleh
Shahwan, Moyad
Al Ani, Mina
Habeb, Mustafa
Jairoun, Maimona
Zyoud, Sa’ed H.
Alkhanani, Mustfa Faisal
Alhasani, Reem Hasaballah
Hakami, Alqassem Y.
Ainousah, Bayan A.
Alshehri, Fahad S.
Alorfi, Nasser M.
Suliman, Abdulhaq
Community pharmacists’ perspectives on cardiovascular disease pharmaceutical care in the United Arab Emirates: a questionnaire survey-based analysis
title Community pharmacists’ perspectives on cardiovascular disease pharmaceutical care in the United Arab Emirates: a questionnaire survey-based analysis
title_full Community pharmacists’ perspectives on cardiovascular disease pharmaceutical care in the United Arab Emirates: a questionnaire survey-based analysis
title_fullStr Community pharmacists’ perspectives on cardiovascular disease pharmaceutical care in the United Arab Emirates: a questionnaire survey-based analysis
title_full_unstemmed Community pharmacists’ perspectives on cardiovascular disease pharmaceutical care in the United Arab Emirates: a questionnaire survey-based analysis
title_short Community pharmacists’ perspectives on cardiovascular disease pharmaceutical care in the United Arab Emirates: a questionnaire survey-based analysis
title_sort community pharmacists’ perspectives on cardiovascular disease pharmaceutical care in the united arab emirates: a questionnaire survey-based analysis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509554/
https://www.ncbi.nlm.nih.gov/pubmed/37736347
http://dx.doi.org/10.3389/fphar.2023.1237717
work_keys_str_mv AT jairounammarabdulrahman communitypharmacistsperspectivesoncardiovasculardiseasepharmaceuticalcareintheunitedarabemiratesaquestionnairesurveybasedanalysis
AT alhimyarisabaasaleh communitypharmacistsperspectivesoncardiovasculardiseasepharmaceuticalcareintheunitedarabemiratesaquestionnairesurveybasedanalysis
AT shahwanmoyad communitypharmacistsperspectivesoncardiovasculardiseasepharmaceuticalcareintheunitedarabemiratesaquestionnairesurveybasedanalysis
AT alanimina communitypharmacistsperspectivesoncardiovasculardiseasepharmaceuticalcareintheunitedarabemiratesaquestionnairesurveybasedanalysis
AT habebmustafa communitypharmacistsperspectivesoncardiovasculardiseasepharmaceuticalcareintheunitedarabemiratesaquestionnairesurveybasedanalysis
AT jairounmaimona communitypharmacistsperspectivesoncardiovasculardiseasepharmaceuticalcareintheunitedarabemiratesaquestionnairesurveybasedanalysis
AT zyoudsaedh communitypharmacistsperspectivesoncardiovasculardiseasepharmaceuticalcareintheunitedarabemiratesaquestionnairesurveybasedanalysis
AT alkhananimustfafaisal communitypharmacistsperspectivesoncardiovasculardiseasepharmaceuticalcareintheunitedarabemiratesaquestionnairesurveybasedanalysis
AT alhasanireemhasaballah communitypharmacistsperspectivesoncardiovasculardiseasepharmaceuticalcareintheunitedarabemiratesaquestionnairesurveybasedanalysis
AT hakamialqassemy communitypharmacistsperspectivesoncardiovasculardiseasepharmaceuticalcareintheunitedarabemiratesaquestionnairesurveybasedanalysis
AT ainousahbayana communitypharmacistsperspectivesoncardiovasculardiseasepharmaceuticalcareintheunitedarabemiratesaquestionnairesurveybasedanalysis
AT alshehrifahads communitypharmacistsperspectivesoncardiovasculardiseasepharmaceuticalcareintheunitedarabemiratesaquestionnairesurveybasedanalysis
AT alorfinasserm communitypharmacistsperspectivesoncardiovasculardiseasepharmaceuticalcareintheunitedarabemiratesaquestionnairesurveybasedanalysis
AT sulimanabdulhaq communitypharmacistsperspectivesoncardiovasculardiseasepharmaceuticalcareintheunitedarabemiratesaquestionnairesurveybasedanalysis